Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates?
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Syndax Pharmaceuticals, Inc.
Posts Tagged ‘NASDAQ:SNDX’
10 Most Promising Cancer Stocks According to Wall Street Analysts
Regardless of the state of the economy, the pharmaceutical business has continued to be one of the healthcare market's most robust sectors thanks to the consistent need for medications...
Why Syndax Pharmaceuticals (SNDX) is One of the Best Small Cap Stocks to Buy for 10x Potential
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is one of the best small cap stocks to buy for 10x potential.
15 Best Small Cap Stocks to Buy for 10x Potential
On May 11, Dan Niles, Niles Investment Management founder, appeared on CNBC’s ‘The Exchange’ to talk about his view on equity markets while conducting a comparison with ...
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs
Syndax Pharmaceuticals (NASDAQ:SNDX) is one of the best cancer stocks to invest in now.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. [Operator Instructions].
11 Best Cancer Stocks to Invest In Now
Pharmaceutical companies are a blend of defensive income plays and growth opportunities.
BofA Raised Syndax (SNDX) PT to $28, Cites Heavy Pre-Announcements Lowering Earnings Impact
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising low-cost stocks to buy now.
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast...
Syndax Pharmaceuticals, Inc. (SNDX): A Bull Case Theory
We came across a bullish thesis on Syndax Pharmaceuticals, Inc. on BioEquity Watch’s Substack.
Barclays Raises Syndax (SNDX) PT to $35 on Positive Management Update, Model Rerating
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks with huge upside potential.
10 Most Promising Stocks with Huge Upside Potential
On November 25, Matt Powers, managing partner of Powers Advisory Group, joined CNBC's 'Squawk Box' to discuss what to make of recent volatility and why he believes that value ...
JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating
On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan reduce its price target from $40 to $33, while reiterating its “Overweight” rating.
10 Best Small-Cap Biotech Stocks to Buy According to Analysts
Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2025 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2025 Earnings Call Transcript November 3, 2025Syndax Pharmaceuticals, Inc. beats earnings expectations.
Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best stocks to buy under $20.
10 Best Stocks to Buy Under $20
On September 16, Ali Dibadj, Janus Henderson Investors CEO, joined 'Squawk Box' on CNBC to discuss the latest market trends and suggest that small and mid-cap stocks have enormous...
Regulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals
Headquartered in Massachusetts, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is a commercial-stage oncology company engaged in developing novel combination therapies for cancer.
BTIG Raises Syndax Pharmaceuticals (SNDX) PT to $56 Following Strong Q2 Revenue from Revuforj, Niktimvo
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best small cap stocks with biggest upside potential.
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
11 Best Short Squeeze Stocks to Buy Now
The latest U.S. tariff wave has created a suitable environment where short squeeze investments will thrive.
FDA Priority Review and Revenue Growth Drive Short-Term Upswing for Syndax Pharmaceuticals
Syndax Pharmaceuticals, Inc.
11 Best Short-Term Stocks to Invest in
The latter half of the 2025 market is caught between conflicting signals.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2025 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2025 Earnings Call Transcript August 4, 2025Syndax Pharmaceuticals, Inc. beats earnings expectations.
Syndax’s Revuforj Granted FDA Priority Review for Relapsed/Refractory Mutant NPM1 AML
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts.
16 Most Promising Stocks According to Wall Street Analysts
On July 3, Scott Wren, Wells Fargo senior global market strategist, and Adam Crisafulli, Vital Knowledge founder, joined 'Closing Bell Overtime' on CNBC to talk about the current...
Syndax Pharmaceuticals Publishes Positive Revumenib Data from BEAT AML Trial
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best biotech stocks to invest in now.
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2025 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter and Full Year 2024 Earnings Conference Call. Today's call is being recorded.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2024 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2024 Earnings Call Transcript November 5, 2024Syndax Pharmaceuticals, Inc. beats earnings expectations.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.99.
12 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2022 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter 2022 Conference Call. Today's call is being recorded.
10 Best Stocks to Buy According to Ari Zweiman’s 683 Capital Partners
In this article, we present the list of top 10 stock picks of Ari Zweiman’s 683 Capital Partners at the end of the second quarter.
Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
Hedge Funds Are Crazy About Syndax Pharmaceuticals, Inc. (SNDX)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Should I Avoid Syndax Pharmaceuticals, Inc. (SNDX)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
10 Best Biotech Stocks to Buy According to Alan Frazier’s Frazier Healthcare Partners
In this article, we discuss the 10 best biotech stocks to buy according to Alan Frazier.
Syndax Pharmaceuticals, Inc. (SNDX) Fell Out Of Favor With Hedge Funds
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Is SNDX Stock A Buy or Sell?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Hedge Fund Resource Center
